EXGILIA
Live / Allowed — Published for opposition (as of 08 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 08 Jul 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99928541
- Mark type
- Stylized text
- Filed
- 08 Jul 2026
- Published for opposition
- 08 Sept 2026
- Attorney of record
- Ben Natter
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the diagnosis, treatment, or prevention of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty related diseases or disorders, gynecological disorders, fertility, acromegaly and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, hematological diseases and disorders, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases and disorders, muscle disorders, bone disorders, skeletal disorders, peripheral nervous system disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain; pharmaceutical preparations for aesthetic and therapeutic use, including for the diagnosis, treatment, or prevention of glabellar lines, forehead lines, lateral canthal lines, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations for skin care.
Owner
- Ipsen Pharma S.A.S., Paris, FR
- Ipsen Pharma S.A.S., Paris, FR
Prior registrations
Prosecution history
- 08 Sept 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Sept 2026 — PUBLISHED FOR OPPOSITION
- 02 Sept 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Aug 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Aug 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Aug 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Aug 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Aug 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Aug 2026 — NON-FINAL ACTION E-MAILED
- 05 Aug 2026 — NON-FINAL ACTION WRITTEN
- 27 Jul 2026 — ASSIGNED TO EXAMINER
- 08 Jul 2026 — APPLICATION FILING RECEIPT MAILED
- 08 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 08 Jul 2026 — NEW APPLICATION ENTERED